Integer Holdings Corp (ITGR) - Total Liabilities

Latest as of September 2025: $1.65 Billion USD

Based on the latest financial reports, Integer Holdings Corp (ITGR) has total liabilities worth $1.65 Billion USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Integer Holdings Corp cash flow conversion to assess how effectively this company generates cash.

Integer Holdings Corp - Total Liabilities Trend (1999–2024)

This chart illustrates how Integer Holdings Corp's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Integer Holdings Corp's assets to evaluate the company's liquid asset resilience ratio.

Integer Holdings Corp Competitors by Total Liabilities

The table below lists competitors of Integer Holdings Corp ranked by their total liabilities.

Company Country Total Liabilities
Virbac SA
PA:VIRP
France €750.28 Million
Tikehau Capital
PA:TKO
France €2.23 Billion
Mivne Real Estate KD Ltd
TA:MVNE
Israel ILA11.74 Billion
Twist Bioscience Corp
NASDAQ:TWST
USA $181.99 Million
Northeast Securities Co Ltd
SHE:000686
China CN¥89.63 Billion
Wanda Cinema Line Corp
SHE:002739
China CN¥15.51 Billion
Sunrun Inc
NASDAQ:RUN
USA $19.19 Billion
OPENLANE, Inc.
NYSE:OPLN
USA $2.78 Billion

Liability Composition Analysis (1999–2024)

This chart breaks down Integer Holdings Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Integer Holdings Corp worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.71 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.95 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.49 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Integer Holdings Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Integer Holdings Corp (1999–2024)

The table below shows the annual total liabilities of Integer Holdings Corp from 1999 to 2024.

Year Total Liabilities Change
2024-12-31 $1.46 Billion +2.47%
2023-12-31 $1.42 Billion +3.39%
2022-12-31 $1.38 Billion +12.17%
2021-12-31 $1.23 Billion +11.51%
2020-12-31 $1.10 Billion -8.31%
2019-12-31 $1.20 Billion -5.18%
2018-12-31 $1.27 Billion -35.23%
2017-12-31 $1.95 Billion -7.23%
2016-12-31 $2.11 Billion -1.14%
2015-12-31 $2.13 Billion +523.69%
2014-12-31 $341.76 Million -1.98%
2013-12-31 $348.65 Million -14.76%
2012-12-31 $409.01 Million -1.22%
2011-12-31 $414.06 Million +18.25%
2010-12-31 $350.15 Million -22.33%
2009-12-31 $450.82 Million -4.74%
2008-12-31 $473.24 Million +38.71%
2007-12-31 $341.18 Million +37.50%
2006-12-31 $248.13 Million +1.57%
2005-12-31 $244.31 Million +10.03%
2004-12-31 $222.03 Million +9.43%
2003-12-31 $202.90 Million +92.53%
2002-12-31 $105.39 Million +11.31%
2001-12-31 $94.68 Million +106.66%
2000-12-31 $45.81 Million -68.05%
1999-12-31 $143.37 Million --

About Integer Holdings Corp

NYSE:ITGR USA Medical Devices
Market Cap
$3.02 Billion
Market Cap Rank
#4977 Global
#1574 in USA
Share Price
$86.29
Change (1 day)
+0.51%
52-Week Range
$63.32 - $122.97
All Time High
$144.36
About

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-v… Read more